CAPRICOR THERAPEUTICS, INC.
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
CAPR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US14070B3096
- LEI:
- Country:
- United States of America
- Address:
- 10865 ROAD TO THE CURE, 92121 SAN DIEGO
- Website:
- https://capricor.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics and biologics. The company's scientific platform is centered on its multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science. Capricor aims to create a new class of medicines to treat and prevent a broad range of serious and rare diseases with significant unmet medical needs, including a primary focus on Duchenne muscular dystrophy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CAPRICOR THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CAPRICOR THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CAPRICOR THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
